Drug Shortage Report for MENACTRA
Report ID | 6731 |
Drug Identification Number | 02279924 |
Brand name | MENACTRA |
Common or Proper name | Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine |
Company Name | SANOFI PASTEUR LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | MENINGOCOCCAL POLYSACCHARIDE-DIPHTHERIA TOXOID CONJUGATE, GROUP A MENINGOCOCCAL POLYSACCHARIDE-DIPHTHERIA TOXOID CONJUGATE, GROUP C MENINGOCOCCAL POLYSACCHARIDE-DIPHTHERIA TOXOID CONJUGATE, GROUP W 135 MENINGOCOCCAL POLYSACCHARIDE-DIPHTHERIA TOXOID CONJUGATE, GROUP Y |
Strength(s) | 4.0 μG 4.0 μG 4.0 μG 4.0 μG |
Dosage form(s) | Solution |
Route of administration | INTRAMUSCULAR |
Packaging size | 5 x 0.5 mL vials |
ATC code | J07AH |
ATC description | BACTERIAL VACCINES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2017-11-22 |
Actual start date | 2017-11-22 |
Estimated end date | 2018-01-15 |
Actual end date | 2018-01-18 |
Shortage status | Resolved |
Updated date | 2018-01-22 |
Company comments | Menactra lot# U5988AB was released to the market on January 18, 2018. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1755 STEELES AVENUE WEST TORONTO, ONTARIO CANADA M2R 3T4 |
Company contact information | Customer Service/Service à la clientèle: 1-800-268-4171 Vaccine Information Service/Service d'information sur les vaccins: 416-667-2611 or 1-888-621-1146 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2018-01-22 | French | Compare |
v8 | 2018-01-22 | English | Compare |
v7 | 2018-01-22 | French | Compare |
v6 | 2018-01-22 | English | Compare |
v5 | 2017-11-23 | English | Compare |
v4 | 2017-11-22 | French | Compare |
v3 | 2017-11-22 | English | Compare |
v2 | 2017-04-13 | French | Compare |
v1 | 2017-04-13 | English | Compare |
Showing 1 to 9 of 9